• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于逐次型 II 截尾样本评估 omega 分布的寿命性能指数。

Evaluating the lifetime performance index of omega distribution based on progressive type-II censored samples.

机构信息

Department of Mathematics and Computer Science, Faculty of Science, Menoufia University, Shebin El-Kom, Egypt.

出版信息

Sci Rep. 2024 Mar 8;14(1):5694. doi: 10.1038/s41598-024-55511-w.

DOI:10.1038/s41598-024-55511-w
PMID:38459084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11319780/
Abstract

Besides achieving high quality products, statistical techniques are applied in many fields associated with health such as medicine, biology and etc. Adhering to the quality performance of an item to the desired level is a very important issue in various fields. Process capability indices play a vital role in evaluating the performance of an item. In this paper, the larger-the-better process capability index for the three-parameter Omega model based on progressive type-II censoring sample is calculated. On the basis of progressive type-II censoring the statistical inference about process capability index is carried out through the maximum likelihood. Also, the confidence interval is proposed and the hypothesis test for estimating the lifetime performance of products. Gibbs within Metropolis-Hasting samplers procedure is used for performing Markov Chain Monte Carlo (MCMC) technique to achieve Bayes estimation for unknown parameters. Simulation study is calculated to show that Omega distribution's performance is more effective. At the end of this paper, there are two real-life applications, one of them is about high-performance liquid chromatography (HPLC) data of blood samples from organ transplant recipients. The other application is about real-life data of ball bearing data. These applications are used to illustrate the importance of Omega distribution in lifetime data analysis.

摘要

除了实现高质量的产品外,统计技术还广泛应用于与健康相关的许多领域,如医学、生物学等。坚持将物品的质量性能保持在期望的水平是各个领域非常重要的问题。过程能力指数在评估物品的性能方面起着至关重要的作用。在本文中,基于逐次型 II 截尾样本计算了基于三参数 Omega 模型的大即好过程能力指数。在逐次型 II 截尾的基础上,通过最大似然法对过程能力指数进行了统计推断。此外,还提出了置信区间,并进行了寿命性能的假设检验。吉布斯在马尔可夫链蒙特卡罗(MCMC)技术中使用 metropolis-hasting 采样器程序,以实现未知参数的贝叶斯估计。模拟研究表明,Omega 分布的性能更有效。本文最后有两个实际应用,一个是器官移植受者血液样本的高效液相色谱(HPLC)数据,另一个是实际的球轴承数据。这些应用旨在说明 Omega 分布在寿命数据分析中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cf/11319780/f6ae16d82d52/41598_2024_55511_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cf/11319780/5ca0868f8ef8/41598_2024_55511_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cf/11319780/f6ae16d82d52/41598_2024_55511_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cf/11319780/5ca0868f8ef8/41598_2024_55511_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cf/11319780/f6ae16d82d52/41598_2024_55511_Fig2_HTML.jpg

相似文献

1
Evaluating the lifetime performance index of omega distribution based on progressive type-II censored samples.基于逐次型 II 截尾样本评估 omega 分布的寿命性能指数。
Sci Rep. 2024 Mar 8;14(1):5694. doi: 10.1038/s41598-024-55511-w.
2
Estimations of competing lifetime data from inverse Weibull distribution under adaptive progressively hybrid censored.自适应逐步混合截尾下逆 Weibull 分布竞争寿命数据的估计。
Math Biosci Eng. 2022 Apr 18;19(6):6252-6275. doi: 10.3934/mbe.2022292.
3
Progressive censoring schemes for marshall-olkin pareto distribution with applications: Estimation and prediction.渐进式截尾方案在马歇尔-奥尔金帕累托分布中的应用:估计和预测。
PLoS One. 2022 Jul 27;17(7):e0270750. doi: 10.1371/journal.pone.0270750. eCollection 2022.
4
Estimations of Generalized Exponential Distribution Parameters Based on Type I Generalized Progressive Hybrid Censored Data.基于 I 型广义逐次混合截尾数据的广义指数分布参数估计。
Comput Math Methods Med. 2022 Mar 29;2022:8058473. doi: 10.1155/2022/8058473. eCollection 2022.
5
Statistical inference with joint progressive censoring for two populations using power Rayleigh lifetime distribution.使用幂瑞利寿命分布对两个群体进行联合渐进删失的统计推断。
Sci Rep. 2023 Mar 7;13(1):3832. doi: 10.1038/s41598-023-30392-7.
6
One- and Two-Sample Predictions Based on Progressively Type-II Censored Carbon Fibres Data Utilizing a Probability Model.基于概率模型的逐步 II 型截尾碳纤维数据的单一样本和双样本预测。
Comput Intell Neurosci. 2022 May 12;2022:6416806. doi: 10.1155/2022/6416806. eCollection 2022.
7
Inferences for Weibull Fréchet Distribution Using a Bayesian and Non-Bayesian Methods on Gastric Cancer Survival Times.贝叶斯和非贝叶斯方法在胃癌生存时间中的威布尔-弗雷歇分布推断。
Comput Math Methods Med. 2021 May 26;2021:9965856. doi: 10.1155/2021/9965856. eCollection 2021.
8
Asymmetric Power Hazard Distribution for COVID-19 Mortality Rate under Adaptive Type-II Progressive Censoring: Theory and Inferences.适应型 II 类渐进删失下 COVID-19 死亡率的非对称幂风险分布:理论与推论。
Comput Intell Neurosci. 2022 Apr 20;2022:5134507. doi: 10.1155/2022/5134507. eCollection 2022.
9
Parametric inference on partially accelerated life testing for the inverted Kumaraswamy distribution based on Type-II progressive censoring data.基于 II 型序贯截尾数据的倒 Kumaraswamy 分布部分加速寿命试验的参数推断。
Math Biosci Eng. 2023 Jan;20(2):1674-1694. doi: 10.3934/mbe.2023076. Epub 2022 Nov 4.
10
Statistical inference for Gompertz distribution under adaptive type-II progressive hybrid censoring.自适应II型渐进混合删失下Gompertz分布的统计推断
J Appl Stat. 2022 Oct 21;51(3):451-480. doi: 10.1080/02664763.2022.2136147. eCollection 2024.

本文引用的文献

1
Assessing the Lifetime Performance Index with Digital Inferences of Power Hazard Function Distribution Using Progressive Type-II Censoring Scheme.使用渐进型 II 截尾方案对功率危害函数分布的数字推断进行寿命性能指数评估。
Comput Intell Neurosci. 2022 Feb 16;2022:6467724. doi: 10.1155/2022/6467724. eCollection 2022.
2
Evaluation of the lifetime performance index on first failure progressive censored data based on Topp Leone Alpha power exponential model applied on HPLC data.基于应用于 HPLC 数据的 Topp Leone Alpha 幂指数模型的首次失效渐进截尾数据的寿命性能指数评估。
J Biopharm Stat. 2021 Sep 3;31(5):565-582. doi: 10.1080/10543406.2021.1895192. Epub 2021 May 24.